Home Link
  • Sign up for free
  • Log in to your account
  • Upload for free
  • Upload for free
  • Listen
    • Live now
    • Genres
    • Trending
    • Community
    • Premium for listeners
    • Unlimited replaysPlay shows as many times as you like
    • Offline listeningDownload shows and listen on the go
    • No adsEnjoy uninterrupted listening
    • Upfront tracklistsSee the full tracklist from the start
  • Creator tools
    • Pro for creators
    • Unlimited uploadsShare infinite shows and tracks
    • Live streamingBroadcast music without takedowns
    • HQ audioEnhance the quality of your uploads
    • MonetizationMake money with Tips & Subscriptions
    • StatsUse listener insights to up your game
    • Host taggingPublish one show to multiple profiles
    • CustomizationPersonalize your profile
    • PostsSend direct messages to your fans
    • Upgrade
    • Pro for CreatorsUpload unlimited shows and live stream without takedowns.
      when paid annually,
    • Premium for listenersListen to your favorite DJs and shows offline and without limits.
  • Appearance
    • Blog
    • Terms of use
    • Support
    • Privacy policy
    • About us
    • Jobs
    • Developers
  • HomeLive nowGenresTrendingLibraryPro for creatorsPremium for Listeners

    Fostamatinib

    Get the Mixcloud app

    App StoreGoogle Play Store
    • Blog
    • Terms of use
    • Support
    • Privacy policy
    • About us
    • Jobs
    • Developers

    Partners

    • TrackdropMusic promotion
    • EncoreGig bookings

    Popular

    Latest
    FirstWord Pharmaceutical News for Wednesday, June 5, 2013
    Track
    FirstWord Pharmaceutical News
    13 years ago
    FirstWord Pharmaceutical News for Wednesday, June 5, 2013

    astrazeneca

    fostamatinib

    johnson & johnson

    bristol-myers squibb

    aveo oncology

    +5
    +4
    +4
    +4
    +3
    +3
    +3
    +2
    +2
    10:26

    astrazeneca

    fostamatinib

    johnson & johnson

    bristol-myers squibb

    aveo oncology

    +5
    +4
    +4
    +4
    +3
    +3
    +3
    +2
    +2
    FirstWord Pharmaceutical News for Thursday, September 30, 2010
    Track
    FirstWord Pharmaceutical News
    10 years ago
    FirstWord Pharmaceutical News for Thursday, September 30, 2010

    sanofi-aventis

    genzyme

    prolia

    fostamatinib

    tamiflu

    +5
    +5
    +4
    +4
    +3
    +2
    +2
    +2
    07:49

    sanofi-aventis

    genzyme

    prolia

    fostamatinib

    tamiflu

    +5
    +5
    +4
    +4
    +3
    +2
    +2
    +2
    FirstWord Pharmaceutical News for Friday, December 14, 2012
    Track
    FirstWord Pharmaceutical News
    13 years ago
    FirstWord Pharmaceutical News for Friday, December 14, 2012

    eli lilly

    tabalumab

    astrazeneca

    fostamatinib

    oncolytics

    +4
    +4
    +4
    +3
    +3
    +2
    +2
    +2
    06:33

    eli lilly

    tabalumab

    astrazeneca

    fostamatinib

    oncolytics

    +4
    +4
    +4
    +3
    +3
    +2
    +2
    +2
    FirstWord Pharmaceutical News for Wednesday, February 17, 2010
    Track
    FirstWord Pharmaceutical News
    16 years ago
    FirstWord Pharmaceutical News for Wednesday, February 17, 2010

    merck & co.

    anaemia drugs

    fostamatinib

    counterfeit drugs

    +4
    +3
    +3
    +3
    +2
    +2
    +2
    +1
    10:55

    merck & co.

    anaemia drugs

    fostamatinib

    counterfeit drugs

    +4
    +3
    +3
    +3
    +2
    +2
    +2
    +1
    There is no more content to load